FDA — authorised 30 June 2011
- Application: NDA022569
- Marketing authorisation holder: BTCP PHARMA
- Local brand name: LAZANDA
- Indication: SPRAY, METERED — NASAL
- Status: approved
🇺🇸 Lazanda in United States
FDA authorised Lazanda on 30 June 2011
Marketing authorisations
FDA
- Status: approved
Lazanda in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Lazanda approved in United States?
Yes. FDA authorised it on 30 June 2011; FDA has authorised it.
Who is the marketing authorisation holder for Lazanda in United States?
BTCP PHARMA holds the US marketing authorisation.